Yann Godet

4PUBLICATIONS
43CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

Myriam Ben Khelil, Maxime Fredon, Nawfel Adib

|May 31, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.

Maxime Fredon, Margaux Poussard, Sabeha Biichlé

|Apr 12, 2024
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy.

Valentine De Castro, Jeanne Galaine, Romain Loyon

|Oct 14, 2021
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells.

Chrystel Marton, Patricia Mercier-Letondal, Romain Loyon

Pageof 1